# High-Risk Breast Duct Epithelium

> **NCT00028340** · — · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 156 (actual)

## Conditions studied

- Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00028340
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2003-02-20
- **Primary completion:** 2022-12-16
- **Final completion:** 2022-12-16
- **Target enrollment:** 156 (ACTUAL)
- **Last updated:** 2023-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00028340

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00028340, "High-Risk Breast Duct Epithelium". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00028340. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*